2014		2015		2016		Rate(Cases per 100,000 per quarter)		Quarterly Rate Comparison
Disease	Q4 No.	YTD No.	Q4 No.	YTD No.	Q4 No.	YTD No.	Qtr4 (2011-2015 aggregated)	Qtr4 (2016)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	.	12	7	24	6	27	0.16	0.28
HEPATITIS A	0	.	.	11	.	12	0.07	0.14
HEPATITIS B (ACUTE)	.	17	5	19	6	18	0.20	0.28
INFLUENZA**	114	628	67	519	137	705	3.71	6.44	X
MEASLES	0	0	0	9	0	0	0.00	0.00
MUMPS	0	.	0	0	.	.	0.01	0.05
PERTUSSIS	.	52	9	89	7	30	0.55	0.33
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
CHLAMYDIA	2432	10145	2612	10089	2938	11337	112.89	138.06	X
GONORRHEA	785	2762	801	2987	1002	3632	31.24	47.08	X
HIV	82	296	79	314	82	429	3.34	3.85
SYPHILIS (EARLY LATENT)	77	308	108	401	90	445	3.38	4.23
SYPHILIS (PRIMARY & SECONDARY)	63	269	85	296	112	375	2.66	5.26	X
Stage 3 HIV (AIDS)	42	202	37	166	41	207	2.25	1.93
ENTERICS
AMEBIASIS	0	.	.	11	.	8	0.07	0.05
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.01	0.00
CAMPYLOBACTERIOSIS	20	100	19	101	33	121	1.03	1.55
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	0	.	.	6	.	.	0.04	0.05
GIARDIA	14	44	8	31	12	50	0.56	0.56
ROTAVIRUS	6	53	.	68	24	54	0.19	1.13	X
SALMONELLOSIS	26	119	40	176	30	148	2.44	1.41	X
SHIGA-TOXIN PRODUCING E. COLI#	.	19	5	35	9	47	0.35	0.42
SHIGELLOSIS	10	28	10	31	10	52	0.42	0.47
TYPHOID FEVER	.	.	.	.	0	.	0.03	0.00
VIBRIO (NON-CHOLERA)	0	.	0	.	0	.	0.01	0.00
YERSINIOSIS	.	.	0	0	.	.	0.02	0.05
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	.	0.00	0.00
COCCIDIOIDOMYCOSIS	15	61	39	100	24	75	1.12	1.13
DENGUE FEVER	0	.	0	.	0	0	0.02	0.00
ENCEPHALITIS	0	.	0	.	0	.	0.00	0.00
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	.	0	.	0	0	0.00	0.00
HEPATITIS C (ACUTE)	0	.	0	7	.	22	0.03	0.19
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.00	0.00
LEGIONELLOSIS	.	21	.	21	.	24	0.12	0.14
LEPROSY (HANSEN’S DISEASE)	0	.	0	0	0	0	0.00	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	.	0	.	.	.	0.01	0.05
LYME DISEASE	0	.	0	5	0	12	0.01	0.00
MALARIA	.	8	.	5	.	6	0.12	0.05
MENINGITIS, ASEPTIC/VIRAL	9	41	.	31	10	29	0.37	0.47
MENINGITIS, BACTERIAL	.	12	.	15	.	31	0.10	0.05
MENINGOCOCCAL DISEASE	.	.	0	0	.	7	0.01	0.14
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	0	.	0.00	0.00
Q FEVER	0	0	0	.	0	.	0.00	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	0	.	0.00	0.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)	203	816	56	1159	529	1200	8.31	24.86	X
STREPTOCOCCUS PNEUMONIAE, IPD###	13	77	24	99	43	149	0.92	2.02	X
TOXIC SHOCK SYN	0	0	0	0	0	0	0.00	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	.	11	7	15	.	18	0.14	0.14
TUBERCULOSIS	10	66	12	71	8	44	0.71	0.38
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (ENCEPHALITIS)	0	.	0	.	0	.	0.00	0.00
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.02	0.00
ZIKA VIRUS DISEASE, CONGENITAL~	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS DISEASE, NON-CONGENITAL~	0	0	0	0	0	16	0.00	0.00
ZIKA VIRUS INFECTION, CONGENITAL~	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS INFECTION, NON-CONGENITAL~	0	0	0	0	.	.	0.00	0.05

*Due to software transition STD data since 2014 are not comparable with those in previous years. Rate denominators are interpolated population estimates/projections using demographic data under ongoing revisions by the state demographer. Use of onset date in data aggregation for cases other than STD or TB (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases that are reportable to CDC. HIV/AIDS/TB case counts provided by Office of Disease Surveillance. Data suppression denoted by ‘.’ applies if number of cases <5. Quarterly disease total (excluding STD and TB cases)=904(reported total=5177). Quarterly congenital syphilis cases (suppression applied) for 2014-2016 were .,.,.(YTD totals of .,6,9) respectively.
~Zika case definitions added in 2016.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).